NCT07194694View on ClinicalTrials.gov

Dexmedetomidine vs Ketamine as Adjuvants to Bupivacaine in Transversus Abdominus Plane Block in Inguinal Hernioplasty

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 2, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

January 10, 2026

Conditions
Postoperative Pain Relief
Interventions
DRUG

Dexmedetomidine & Bupivacaine.

Group A (Dexmedetomidine Group): patients will receive 20 ml solution containing 1 mg/kg bupivacaine + 1mcg/kg dexmedetomidine +normal saline.

DRUG

ketamine and bupivacaine injection

Group K (ketamine Group): patients will receive 20 ml solution containing 1 mg/kg bupivacaine+0.5 mg/kg ketamine + normal saline.

DRUG

Bupivacaine

Group C (Control Group): Patients will receive 20 ml solution containing 1 mg/kg bupivacaine + normal saline.

Trial Locations (1)

Unknown

Ain Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER